High single-dose alternate-day corticosteroid regimens in treatment of polymyositis

1985 ◽  
Vol 232 (3) ◽  
pp. 175-178 ◽  
Author(s):  
Makoto Uchino ◽  
Shukuro Araki ◽  
Osamu Yoshida ◽  
Kazutoshi Uekawa ◽  
Jinro Nagata
Keyword(s):  

Author(s):  
M. Massaccesi ◽  
N. Dinapoli ◽  
L. Boldrini ◽  
L. Cervone ◽  
L. Placidi ◽  
...  


2016 ◽  
Vol 23 (6) ◽  
pp. 744-746 ◽  
Author(s):  
Jamie M. Rosini ◽  
Joshua J. Davis ◽  
Jeffrey Muenzer ◽  
Brian J. Levine ◽  
Mia A. Papas ◽  
...  


1998 ◽  
Vol 20 (6) ◽  
pp. 640-645 ◽  
Author(s):  
Lars Möllgård ◽  
Ulf Tidefelt ◽  
Britt Sundman-Engberg ◽  
Christina Löfgren ◽  
Sören Lehman ◽  
...  


Lung Cancer ◽  
2008 ◽  
Vol 60 (2) ◽  
pp. 193-199 ◽  
Author(s):  
Peter Fritz ◽  
Hans-Jörg Kraus ◽  
Thomas Blaschke ◽  
Werner Mühlnickel ◽  
Konstantin Strauch ◽  
...  


2013 ◽  
Vol 106 ◽  
pp. S148-S149
Author(s):  
C. Herskind


2017 ◽  
Vol 61 (4) ◽  
Author(s):  
Zackery P. Bulman ◽  
Michael J. Satlin ◽  
Liang Chen ◽  
Barry N. Kreiswirth ◽  
Beom Soo Shin ◽  
...  

ABSTRACT Pharmacodynamics of a polymyxin B, meropenem, and rifampin triple combination were examined against Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) ST258. In time-kill experiments against three KPC-Kp isolates, triple combination generated 8.14, 8.19, and 8.29 log10 CFU/ml reductions within 24 h. In the hollow-fiber infection model, the triple combination caused maximal killing of 5.16 log10 CFU/ml at 78 h and the time required for regrowth was more than doubled versus the 2-drug combinations. Remarkably, combinations with a high single-dose polymyxin B burst plus rifampin preserved KPC-Kp polymyxin susceptibility (MIC240 h = 0.5 mg/liter) versus the same combination with traditionally dosed polymyxin B, where resistance was amplified (MIC240 h = 32 mg/liter).



2014 ◽  
Vol 90 (1) ◽  
pp. S774-S775
Author(s):  
S.S. Rao ◽  
C.M. Thompson ◽  
D. Higginson ◽  
Y. Yamada ◽  
A. Haimovitz-Freidman ◽  
...  
Keyword(s):  


1991 ◽  
Vol 124 (1) ◽  
pp. 49-55 ◽  
Author(s):  
I. BRUYNZEEL ◽  
W. BERGMAN ◽  
H.M. HARTEVELT ◽  
C.C.A. KENTER ◽  
E.A. VELDE ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document